Joint Estimation of Remission and Response for Methotrexate-Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta-Analysis.

Gyanendra PokharelRob DeardonCheryl C M BarnabeVivian BykerkSusan J BartlettLouis BessetteGilles BoireCarol A HitchonEdward KeystoneJanet E PopeOrit SchieirDiane TinCarter ThorneGlen Stewart Hazlewoodnull null

Published in: ACR open rheumatology (2019)

Borrowing the strength of correlation between outcomes allowed us to demonstrate a statistically significant benefit for remission across most MTX-based DMARD combinations, including triple therapy.

Keyphrases

disease activity
rheumatoid arthritis
systematic review
systemic lupus erythematosus
ankylosing spondylitis
ulcerative colitis
meta analyses
high dose
interstitial lung disease
case control
stem cells
randomized controlled trial
type diabetes
replacement therapy